Common use of Compounds for Screening Clause in Contracts

Compounds for Screening. During the Research Phase, CNSI will make all CNSI Compounds (but excluding the Excluded Compounds) available for screening as selected by the Research Management Committee, along with the structures and properties of such CNSI Compounds. In addition, pursuant to the Research Plan, CNSI will synthesize additional compounds with expected activity for the Validated Target(s). The Research Management Committee may also select for screening appropriate Allergan Compounds reasonably proposed for screening by Allergan. In addition, the Research Management Committee may agree to obtain from Third Parties rights to screen compounds owned or controlled by such Third Parties; provided, however, that if there would be any amounts payable to any such Third Party for screening such compounds or making, using or selling products containing such compounds, no such Third Party compounds will be screened without the consent of both Parties.